SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

腸疾患検査市場

出版：MarketsandMarkets

Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region – Global Forecast to 2026
種別英文調査報告書
出版MarketsandMarkets
出版年月2021年 8月
ページ数274
図表数343
–
レポート目次 お問合せ
–技術（従来型および迅速）、最終用途[食品（肉、鶏肉、シーフード、乳製品、加工食品、果物と野菜）、水]、病原体検査済み、地域 別The global market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. Foodborne illnesses have affected socioeconomic development by straining health care systems and trade. The factors fueling the growth of the enteric disease testing market are the implementation of stringent regulations related to contaminant detection, growth in consumer awareness, and humid atmospheric conditions, which are leading to an increase in contamination in food. In order to address enteric disease concerns, caused by foodborne illness, skey players in the various regions will need to further improve upon their food safety monitoring programs.The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market. Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders. The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood productsThe North American region is estimated to account for the largest market share in the global enteric disease testing market. The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.Break-up of PrimariesBy Company Type: Tier 1: 65%, Tier 2: 20%, and Tier 3: 15%By Designation: C-Level – 45%, Director Level – 30%, others- 25% By Region: North America – 10%, Europe – 45%, Asia Pacific – 25%, South America – 5%, and Rest of the World (RoW) – 15%. Leading players profiled in this report•SGS SA (Switzerland)•Eurofins Scientific (Luxembourg)•Intertek Group plc (UK)•Bureau Veritas (France)•ALS Limited (Australia)•TÜV SÜD (Germany)•NEOGEN Corporation (US)•Mérieux NutriSciences (US)•AsureQuality (New Zealand)Research Coverage This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges. Reasons to buy this report•To get a comprehensive overview of the enteric disease testing market •To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them. •To gain insights about the major countries/regions, in which the enteric disease testing market is flourishing.

目次

1INTRODUCTION301.1OBJECTIVES OF THE STUDY301.2MARKET DEFINITION301.3STUDY SCOPE31FIGURE 1ENTERIC DISEASE TESTING MARKET SEGMENTATION311.3.1REGIONAL SEGMENTATION311.4INCLUSIONS & EXCLUSIONS321.4.1PERIODIZATION CONSIDERED331.5CURRENCY CONSIDERED33TABLE 1USD EXCHANGE RATES, 2015–2019341.6STAKEHOLDERS342RESEARCH METHODOLOGY352.1RESEARCH DATA35FIGURE 2ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN352.1.1SECONDARY DATA362.1.1.1Key data from secondary sources362.1.2PRIMARY DATA372.1.2.1Key industry insights372.1.2.2Breakdown of primary interviews38FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION382.2MARKET SIZE ESTIMATION392.2.1BOTTOM-UP APPROACH392.2.2TOP-DOWN APPROACH39FIGURE 4MARKET SIZE ESTIMATION METHODOLOGY APPROACH402.3DATA TRIANGULATION41FIGURE 5DATA TRIANGULATION METHODOLOGY412.3.1ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE42FIGURE 6MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020422.3.2ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE422.4RESEARCH ASSUMPTIONS432.5RESEARCH LIMITATIONS442.6MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19442.7SCENARIO-BASED MODELLING452.8COVID-19 HEALTH ASSESSMENT45FIGURE 7COVID-19: GLOBAL PROPAGATION45FIGURE 8COVID-19 PROPAGATION: SELECT COUNTRIES462.9COVID-19 ECONOMIC ASSESSMENT47FIGURE 9REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020472.9.1COVID-19 ECONOMIC IMPACT—SCENARIO ASSESSMENT48FIGURE 10CRITERIA IMPACTING GLOBAL ECONOMY48FIGURE 11SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY493EXECUTIVE SUMMARY514PREMIUM INSIGHTS544.1OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET544.2NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY554.3ENTERIC DISEASE TESTING MARKET, BY PATHOGEN55FIGURE 18SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020554.4ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY564.5ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT564.6ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS575MARKET OVERVIEW585.1INTRODUCTION585.2MACROECONOMIC INDICATORS585.2.1INCREASE IN FOODBORNE ILLNESSES58FIGURE 22NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)59FIGURE 23US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020595.3MARKET DYNAMICS60FIGURE 24ENTERIC DISEASE TESTING MARKET DYNAMICS605.3.1DRIVERS605.3.1.1Increase in the number of food recalls60FIGURE 25EU: NUMBER OF FOOD RECALLS, 2017–202061FIGURE 26US: REASONS FOR RECALL OF FOOD, 2020615.3.1.2Rise in demand for convenience foods61FIGURE 27READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 202062FIGURE 28RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT)625.3.1.3Increase in global trade owing to higher disposable income among consumers62FIGURE 29GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 2016–2018 (USD BILLION)63FIGURE 30COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)635.3.2RESTRAINTS645.3.2.1Lack of proper regulations governing pathogen testing in the developing economies64 5.3.3OPPORTUNITIES645.3.3.1Technological innovations in the food safety testing industry645.3.3.2R&D investment directed toward the development of PCR technology for improved pathogen testing64TABLE 2R&D INVESTMENT BY MAJOR COMPANIES655.3.4CHALLENGES655.3.4.1High cost associated with testing of food and water656INDUSTRY TRENDS666.1INTRODUCTION666.2REGULATORY FRAMEWORK666.2.1INTRODUCTION666.2.2INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS666.2.2.1Codex Alimentarius Commission (CAC)666.2.2.2Global Food Safety Initiative (GFSI)666.2.3NORTH AMERICA676.2.3.1US regulations676.2.3.2Mexico686.2.3.3Canada686.2.4EUROPE696.2.4.1Microbiological criteria regulation706.2.4.2General food law for food safety706.2.4.3Germany706.2.4.4UK716.2.4.5France716.2.4.6Italy716.2.4.7Poland726.2.5ASIA PACIFIC726.2.5.1China72TABLE 3PATHOGEN LIMITS FOR FOOD726.2.5.2India736.2.5.3Japan746.2.5.4Australia746.2.5.5New Zealand756.2.6SOUTH AMERICA756.2.6.1Brazil756.2.6.2Ministry of Agriculture, Livestock, and Food Supply (MAPA)756.2.6.3Ministry of Health (MS)756.2.6.4Argentina766.3PORTER’S FIVE FORCES ANALYSIS77TABLE 4ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS776.3.1THREAT OF NEW ENTRANTS776.3.2THREAT OF SUBSTITUTES776.3.3BARGAINING POWER OF SUPPLIERS786.3.4BARGAINING POWER OF BUYERS786.3.5DEGREE OF COMPETITION786.4MARKET ECOSYSTEM79FIGURE 31ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP796.4.1UPSTREAM796.4.2DOWNSTREAM79TABLE 5COMPANY MARKET ECOSYSTEM806.5SUPPLY CHAIN ANALYSIS81FIGURE 32REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET816.5.1R&D826.5.2PRODUCTION826.5.3PROCESSING & TRANSFORMING826.5.4TRANSPORTATION826.5.5FINAL PREPARATION826.5.6DISTRIBUTION826.6TECHNOLOGY ANALYSIS836.7PATENT ANALYSIS84FIGURE 33PATENT ANALYSIS, 2017-202084TABLE 6KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 2018- 2021856.8CASE STUDIES85TABLE 7AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION856.9DISRUPTIONS IMPACTING BUYERS IN THE MARKET86FIGURE 34THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES866.10IMPACT OF COVID-19 ON MARKET DYNAMICS866.10.1COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT876.10.2COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY877ENTERIC DISEASE TESTING MARKET, BY PATHOGEN887.1INTRODUCTION89FIGURE 35ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021 VS. 2026 (USD MILLION)89TABLE 8PATHOGENESIS OF COMMON PATHOGENS90FIGURE 36US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 201990TABLE 9US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 201991TABLE 10ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)91TABLE 11ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)927.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY PATHOGEN927.1.1.1Realistic Scenario92TABLE 12REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)92TABLE 13REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)937.1.1.2Optimistic Scenario93TABLE 14OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)93TABLE 15OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)947.1.1.3Pessimistic Scenario94TABLE 16PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016–2020 (USD MILLION)94TABLE 17PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021–2026 (USD MILLION)957.1.2E. COLI957.1.2.1Proper food safety testing can limit the incidences of E. coli food poisoning95FIGURE 37US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–201896FIGURE 38TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)96TABLE 18E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)97TABLE 19E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)977.1.3SALMONELLA987.1.3.1Salmonella foodborne infection is found to be severe during summer than in winter98FIGURE 39US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–201898TABLE 20SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)98TABLE 21SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)997.1.4CAMPYLOBACTER997.1.4.1WHO is strengthening disease surveillance to prevent foodborne illness99FIGURE 40US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018100TABLE 22CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)100TABLE 23CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)1007.1.5LISTERIA1017.1.5.1L. monocytogenes causes high hospitalization rate than any other foodborne pathogen101TABLE 24LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)101TABLE 25LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)1017.1.6OTHER PATHOGENS102TABLE 26OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)102TABLE 27OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)1028ENTERIC DISEASE TESTING MARKET, BY END USE1038.1INTRODUCTION104FIGURE 41EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019104FIGURE 42ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021 VS. 2026 (USD MILLION)104TABLE 28ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)105TABLE 29ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)105TABLE 30ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)105TABLE 31ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)1068.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE1068.1.1.1Realistic scenario106TABLE 32REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)106TABLE 33REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)1078.1.1.2Optimistic scenario107TABLE 34OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)107TABLE 35OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)1078.1.1.3Pessimistic scenario108TABLE 36PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)108TABLE 37PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)1088.2FOOD1088.2.1MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING108TABLE 38ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS109FIGURE 43EU: FOODBORNE DISEASE OUTBREAKS, 2017110TABLE 39EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES110TABLE 40US: FOOD RECALLS, 2020111TABLE 41ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2016–2020 (USD MILLION)112TABLE 42ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2021–2026 (USD MILLION)113TABLE 43ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2016–2020 (USD MILLION)113TABLE 44ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2021–2026 (USD MILLION)1138.2.2MEAT, POULTRY, AND SEAFOOD1148.2.2.1Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination114FIGURE 44EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019114TABLE 45ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION)115TABLE 46ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION)115TABLE 47ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2016–2020 (USD MILLION)115TABLE 48ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2021–2026 (USD MILLION)1168.2.3DAIRY PRODUCTS1168.2.3.1Unhygienic storage conditions lead to contamination of dairy products116FIGURE 45EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019117TABLE 49ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION)117TABLE 50ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION)117TABLE 51ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2016–2020 (USD MILLION)118TABLE 52ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2021–2026 (USD MILLION)1188.2.4PROCESSED FOOD1188.2.4.1Ready-To-Eat foods are gaining more traction among consumers118TABLE 53ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION)119TABLE 54ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, BY REGION, 2021–2026 (USD MILLION)119TABLE 55ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION)120TABLE 56ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, BY PATHOGEN, 2021–2026 (USD MILLION)1208.2.5FRUITS & VEGETABLES1208.2.5.1Good handling practices can help in the safe production of fresh produce120TABLE 57ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2016–2020 (USD MILLION)121TABLE 58ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2021–2026 (USD MILLION)121TABLE 59ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2016–2020 (USD MILLION)121TABLE 60ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2021–2026 (USD MILLION)1228.2.6OTHER FOOD APPLICATIONS122TABLE 61ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2016–2020 (USD MILLION)123TABLE 62ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)123TABLE 63ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2016–2020 (USD MILLION)123TABLE 64ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2021–2026 (USD MILLION)1248.3WATER1248.3.1POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS124TABLE 65ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2016–2020 (USD MILLION)124TABLE 66ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2021–2026 (USD MILLION)125TABLE 67ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2016–2020 (USD MILLION)125TABLE 68ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2021–2026 (USD MILLION)1259ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY1269.1INTRODUCTION127FIGURE 46ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)127TABLE 69ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)127TABLE 70ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)1289.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY1289.1.1.1Realistic scenario128TABLE 71REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)128TABLE 72REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)1289.1.1.2Optimistic scenario129TABLE 73OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)129TABLE 74OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)1299.1.1.3Pessimistic scenario129TABLE 75PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016–2020 (USD MILLION)129TABLE 76PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021–2026 (USD MILLION)1299.2TRADITIONAL1309.2.1CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE130TABLE 77TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)130TABLE 78TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)1319.3RAPID131TABLE 79ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, BY REGION, 2016–2020 (USD MILLION)132TABLE 80RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)132TABLE 81RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2016–2020 (USD MILLION)132TABLE 82RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2021–2026 (USD MILLION)1339.3.1CONVENIENCE-BASED1339.3.1.1Helps detect microorganisms based on their biochemical reactions under standard growth conditions1339.3.2POLYMERASE CHAIN REACTION (PCR)1339.3.2.1Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms1339.3.3IMMUNOASSAY1349.3.3.1ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies1349.3.4CHROMATOGRAPHY & SPECTROMETRY1359.3.4.1Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry13510ENTERIC DISEASE TESTING MARKET, BY REGION13610.1INTRODUCTION137FIGURE 47REGION-WISE FOOD SAFETY EVENTS, 2020137FIGURE 48US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026138TABLE 83ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)138TABLE 84ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)13910.1.1COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION13910.1.1.1Realistic scenario139TABLE 85REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)139TABLE 86REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)14010.1.1.2Optimistic scenario140TABLE 87OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)140TABLE 88OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)14010.1.1.3Pessimistic scenario141TABLE 89PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION)141TABLE 90PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION)14110.2NORTH AMERICA141FIGURE 49NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020142TABLE 91NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)143TABLE 92NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)143TABLE 93NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)143TABLE 94NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)144TABLE 95NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)144TABLE 96NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)14410.2.1US14510.2.1.1FSIS is the regulating body that enforces food safety regulations145FIGURE 50NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018145FIGURE 51US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016146TABLE 97US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)146FIGURE 52US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016147TABLE 98US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)147TABLE 99US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)148TABLE 100US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)148TABLE 101US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)14810.2.2CANADA14910.2.2.1Canadian government imposed stringent regulations on exports to ensure food safety149TABLE 102CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)149TABLE 103CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)149TABLE 104CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)150TABLE 105CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)15010.2.3MEXICO15110.2.3.1Rise in the number of foodborne disease cases has increased focus on food safety in the country151TABLE 106MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)151TABLE 107MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)151TABLE 108MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)152TABLE 109MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)15210.3EUROPE152FIGURE 53EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017153FIGURE 54EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020154TABLE 110EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)155TABLE 111EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)155TABLE 112EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)156TABLE 113EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)156TABLE 114EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)156TABLE 115EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)15710.3.1GERMANY15710.3.1.1International food trade has increased food safety risks157FIGURE 55GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019158TABLE 116GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)158TABLE 117GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)159TABLE 118GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)159TABLE 119GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)15910.3.2FRANCE16010.3.2.1Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing160TABLE 120FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)160TABLE 121FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)160TABLE 122FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)161TABLE 123FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16110.3.3SPAIN16110.3.3.1Outbreak of listeriosis will have serious implications on the Spanish meat industry161TABLE 124SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)162TABLE 125SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)162TABLE 126SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)162TABLE 127SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16310.3.4ITALY16310.3.4.1Products of animal origin products are found to be more problematic in this region163TABLE 128ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)163TABLE 129ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)164TABLE 130ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)164TABLE 131ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16410.3.5POLAND16510.3.5.1Increase in incidences of Salmonella outbreaks drives awareness about food safety165TABLE 132POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)165TABLE 133POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)165TABLE 134POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENTS, 2016–2020 (USD MILLION)166TABLE 135POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16610.3.6UK16710.3.6.1Norovirus infection is estimated to occur every year in the UK167TABLE 136UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)167TABLE 137UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)167TABLE 138UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)167TABLE 139UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16810.3.7REST OF EUROPE168TABLE 140REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)168TABLE 141REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)169TABLE 142REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)169TABLE 143REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)16910.4ASIA PACIFIC170TABLE 144ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)170TABLE 145ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)170TABLE 146ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)171TABLE 147ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)171TABLE 148ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)171TABLE 149ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)17210.4.1JAPAN17210.4.1.1E. coli to be the major pathogen found to affect people172TABLE 150JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)172TABLE 151JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)173TABLE 152JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)173TABLE 153JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)17310.4.2CHINA17410.4.2.1Microbial contamination is reported to be the biggest food safety risk174TABLE 154CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)174TABLE 155CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)174TABLE 156CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)175TABLE 157CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)17510.4.3INDIA17510.4.3.1FSSAI to safeguard the quality of food produced175TABLE 158INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)176TABLE 159INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)176TABLE 160INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)176TABLE 161INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)17710.4.4AUSTRALIA & NEW ZEALAND17710.4.4.1Gastroenteritis occurs every year, affecting several people177TABLE 162AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)177TABLE 163AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)178TABLE 164AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)178TABLE 165AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)17810.4.5THAILAND17910.4.5.1Demand for food exports to boost the growth of the market179TABLE 166THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)179TABLE 167THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)179TABLE 168THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)180TABLE 169THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18010.4.6REST OF ASIA PACIFIC180TABLE 170REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)181TABLE 171REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)181TABLE 172REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)181TABLE 173REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18210.5SOUTH AMERICA182TABLE 174SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION)182TABLE 175SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION)183TABLE 176SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)183TABLE 177SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)183TABLE 178SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016–2020 (USD MILLION)184TABLE 179SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18410.5.1BRAZIL18410.5.1.1Export of agricultural produce to boost the demand for enteric disease testing184TABLE 180BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)185TABLE 181BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)185TABLE 182BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)185TABLE 183BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18610.5.2ARGENTINA18610.5.2.1Food companies are taking preventive measures for pathogen infections186TABLE 184ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)186TABLE 185ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)187TABLE 186ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)187TABLE 187ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18710.5.3REST OF SOUTH AMERICA188TABLE 188REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)188TABLE 189REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)188TABLE 190REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)188TABLE 191REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)18910.6REST OF THE WORLD (ROW)189TABLE 192ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016–2020 (USD MILLION)189TABLE 193ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021–2026 (USD MILLION)190TABLE 194ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)190TABLE 195ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)190TABLE 196ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)190TABLE 197ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)19110.6.1SOUTH AFRICA19110.6.1.1Growth in the demand to follow international standards is encouraging enteric disease testing191TABLE 198SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)191TABLE 199SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)192TABLE 200SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)192TABLE 201SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)19210.6.2MIDDLE EAST19310.6.2.1Food safety services are driven by food imports from other countries193TABLE 202MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION)193TABLE 203MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION)193TABLE 204MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION)194TABLE 205MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION)19411COMPETITIVE LANDSCAPE19511.1OVERVIEW19511.2OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET19611.3MARKET SHARE ANALYSIS, 2020197FIGURE 56MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS19711.4COVID-19-SPECIFIC COMPANY RESPONSE19811.4.1SGS SA19811.4.2MERCK KGAA19811.4.3EUROFINS SCIENTIFIC19811.5COMPANY EVALUATION QUADRANT (KEY PLAYERS)19811.5.1STARS19911.5.2EMERGING LEADERS19911.5.3PERVASIVE PLAYERS19911.5.4PARTICIPANTS199FIGURE 57ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)20011.6PRODUCT FOOTPRINT201TABLE 206COMPANY FOOTPRINT, BY TECHNOLOGY201TABLE 207COMPANY FOOTPRINT, BY END-USE202TABLE 208COMPANY FOOTPRINT, BY REGION20311.7COMPANY EVALUATION QUADRANT (START-UP/SME)20411.7.1PROGRESSIVE COMPANIES20411.7.2STARTING BLOCKS20411.7.3RESPONSIVE COMPANIES20411.7.4DYNAMIC COMPANIES204FIGURE 58ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)20511.8COMPETITIVE SCENARIO20511.8.1NEW PRODUCTS LAUNCHES205TABLE 209ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 201920511.8.2DEALS206TABLE 210ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 202120611.8.3OTHER DEVELOPMENTS207TABLE 211ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, MAY 2018- JUNE 202120712COMPANY PROFILES208(Business overview, Products offered, Recent developments & MnM View)*12.1KEY COMPANIES20812.1.1SGS SA208TABLE 212SGS SA: BUSINESS OVERVIEW208FIGURE 59SGS SA: COMPANY SNAPSHOT209TABLE 213SGS SA: PRODUCT OFFERINGS209TABLE 214SGA SA: DEALS210TABLE 215SGS SA: OTHERS21012.1.2MERCK KGAA212TABLE 216MERCK KGAA: BUSINESS OVERVIEW212FIGURE 60MERCK KGAA: COMPANY SNAPSHOT213TABLE 217MERCK KGAA: PRODUCT OFFERINGS21312.1.3THERMO FISHER SCIENTIFIC INC.215TABLE 218THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW215FIGURE 61THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT216TABLE 219THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS216TABLE 220THERMO FISHER SCIENTIFIC INC.: DEALS21812.1.4EUROFINS SCIENTIFIC219TABLE 221EUROFINS SCIENTIFIC: BUSINESS OVERVIEW219FIGURE 62EUROFINS SCIENTIFIC: COMPANY SNAPSHOT220TABLE 222EUROFINS SCIENTIFIC: PRODUCT OFFERINGS220TABLE 223EUROFINS SCIENTIFIC: DEALS221TABLE 224EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS22212.1.5ALS LIMITED223TABLE 225ALS LIMITED: BUSINESS OVERVIEW223FIGURE 63ALS LIMITED: COMPANY SNAPSHOT223TABLE 226ALS LIMITED: PRODUCT OFFERINGS224TABLE 227ALS LIMITED: DEALS224TABLE 228ALS LIMITED: OTHER DEVELOPMENTS22512.1.6ASURE QUALITY226TABLE 229ASURE QUALITY: BUSINESS OVERVIEW226FIGURE 64ASURE QUALITY: COMPANY SNAPSHOT226TABLE 230ASURE QUALITY: PRODUCT OFFERINGS22712.1.7BUREAU VERITAS228TABLE 231BUREAU VERITAS: BUSINESS OVERVIEW228FIGURE 65BUREAU VERITAS: COMPANY SNAPSHOT229TABLE 232BUREAU VERITAS: PRODUCT OFFERINGS22912.1.8INTERTEK231TABLE 233INTERTEK: BUSINESS OVERVIEW231FIGURE 66INTERTEK: COMPANY SNAPSHOT232TABLE 234INTERTEK: PRODUCT OFFERINGS232TABLE 235INTERTEK: DEALS23312.1.9BIO-RAD LABORATORIES, INC.234TABLE 236BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW234FIGURE 67BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT234TABLE 237BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS23512.1.10BECTON DICKINSON237TABLE 238BECTON DICKINSON: BUSINESS OVERVIEW237FIGURE 68BECTON DICKINSON: COMPANY SNAPSHOT238TABLE 239BECTON DICKINSON: PRODUCT OFFERINGS23812.1.113M240TABLE 2403M: BUSINESS OVERVIEW240FIGURE 693M: COMPANY SNAPSHOT240TABLE 2413M: PRODUCT OFFERINGS24112.1.12PERKINELMER, INC.242TABLE 242PERKINELMER, INC.: BUSINESS OVERVIEW242FIGURE 70PERKINELMER, INC.: COMPANY SNAPSHOT243TABLE 243PERKINELMER, INC.: PRODUCT OFFERINGS24412.1.13NEOGEN CORPORATION245TABLE 244NEOGEN CORPORATION: BUSINESS OVERVIEW245FIGURE 71NEOGEN CORPORATION: COMPANY SNAPSHOT245TABLE 245NEOGEN CORPORATION: PRODUCT OFFERINGS24612.1.14MÉRIEUX NUTRISCIENCES248TABLE 246MÉRIEUX NUTRISCIENCES: BUSINESS OVERVIEW248TABLE 247MÉRIEUX NUTRISCIENCES: PRODUCT OFFERINGS248TABLE 248MÉRIEUX NUTRISCIENCES: DEALS24912.1.15TÜV SÜD250TABLE 249TÜV SÜD: BUSINESS OVERVIEW250TABLE 250TÜV SÜD: PRODUCT OFFERINGS250*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies. 12.2OTHER PLAYERS25112.2.1HARDY DIAGNOSTICS251TABLE 251HARDY DIAGNOSTICS: BUSINESS OVERVIEW251TABLE 252HARDY DIAGNOSTICS: PRODUCT OFFERINGS251TABLE 253HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH25212.2.2ROMER LABS253TABLE 254ROMER LABS: BUSINESS OVERVIEW253TABLE 255ROMER LABS: PRODUCT OFFERINGS25312.2.3NOVA BIOLOGICALS254TABLE 256NOVA BIOLOGICALS: BUSINESS OVERVIEW254TABLE 257NOVA BIOLOGICALS: PRODUCT OFFERINGS25412.2.4SYMBIO LABORATORIES255TABLE 258SYMBIO LABORATORIES: BUSINESS OVERVIEW255TABLE 259SYMBIO LABORATORIES: PRODUCT OFFERINGS25512.2.5CERTIFIED LABORATORIES25613ADJACENT AND RELATED MARKETS25713.1INTRODUCTION257TABLE 260ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET25713.2LIMITATIONS25713.3FOOD PATHOGEN TESTING MARKET25713.3.1MARKET DEFINITION25713.3.2MARKET OVERVIEW258TABLE 261E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)259TABLE 262SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)259TABLE 263CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)259TABLE 264LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)26013.4FOOD TESTING KITS MARKET26013.4.1MARKET DEFINITION26013.4.2MARKET OVERVIEW260TABLE 265FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION)261TABLE 266FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2015–2022 (USD MILLION)261TABLE 267FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 2015–2022 (USD MILLION)261TABLE 268FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION)262 13.5MICROBIAL WATER TESTING MARKET26213.5.1MARKET DEFINITION26213.5.2MARKET OVERVIEW263TABLE 269MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION)263TABLE 270MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)263TABLE 271DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)264TABLE 272INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION)26414APPENDIX26514.1DISCUSSION GUIDE26514.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL26914.3AVAILABLE CUSTOMIZATIONS27114.4RELATED REPORTS27214.5AUTHOR DETAILS273

お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    食品・飲料の最新記事8件